(Q44553379)

4 December 2017

title

Activation of the innate immune system as a predictor of cardiovascular mortality in Type 2 diabetes mellitus (English)

1 reference

4 December 2017

1 reference

1 reference

Pickup JC

1

1 reference

4 December 2017

Mattock MB

series ordinal

2

1 reference

4 December 2017

publication date

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

20

1 reference

4 December 2017

issue

9

1 reference

4 December 2017

page(s)

723-726

1 reference

Diabetes mellitus and macrovascular complications. An epidemiological perspective

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

Hyperglycemia and cardiovascular disease in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

Relationship between blood glucose level and mortality in type 2 diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease ? chicken, egg or neither?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

Is type II diabetes mellitus a disease of the innate immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

Serum Sialic Acid Concentration and Coronary Heart Disease in NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

Serum sialic acid concentration and cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

Haematological stress syndrome in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

Prospective study of microalbuminuria as predictor of mortality in NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease--putative association via common antecedents; further evidence from the Whitehall Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00990.X

10.1046/J.1464-5491.2003.00990.X

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference